Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Reet

2 clinical trials in Reet, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Reet at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Reet

Open in trial search
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Antwerp University Hospital

Colon cancer stage III+1

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Antwerp University Hospital

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Reet

What the registry says about research in the country

01 Neuroendocrine Cancer Research

Innovative clinical trials focusing on neuroendocrine tumours are evaluating treatment continuation strategies. These studies examine the effectiveness of maintaining specific therapies after disease progression, with particular attention to patient quality of life outcomes.

  • Treatment Progression Analysis
  • Quality of Life Assessment
  • Imaging-Based Evaluation

Research emphasizes both survival metrics and patient well-being through standardized evaluation frameworks.

02 Colorectal Cancer Studies

Groundbreaking research investigating the potential benefits of acetylsalicylic acid in treating colon cancer. The studies focus on survival rates in patients with stage II and III colon cancer following surgical resection.

  • Long-term Survival Analysis
  • Post-Surgery Treatment
  • Preventive Care Strategies

This research aims to establish new protocols for post-operative care in colon cancer patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.